We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Hearing Examines Drug Pricing, Pushes for More Competition, Compounding
Senate Hearing Examines Drug Pricing, Pushes for More Competition, Compounding
Participants in a Dec. 9, 2015, Senate hearing — which addressed drug price manipulation of generics in uncontested markets — said the best way to stem the practice is to speed competitors to market and consider using compounders.